null
Loading... Please wait...
FREE SHIPPING on All Unbranded Items LEARN MORE
Print This Page

Generative AI in Neurodegenerative Disorders (Innovations, Views, and Obstacles)

List Price: $150.00
SKU:
9788743801757
Quantity:
Minimum Purchase
25 unit(s)
  • Availability: Confirm prior to ordering
  • Branding: minimum 50 pieces (add’l costs below)
  • Check Freight Rates (branded products only)

Branding Options (v), Availability & Lead Times

  • 1-Color Imprint: $2.00 ea.
  • Promo-Page Insert: $2.50 ea. (full-color printed, single-sided page)
  • Belly-Band Wrap: $2.50 ea. (full-color printed)
  • Set-Up Charge: $45 per decoration
FULL DETAILS
  • Availability: Product availability changes daily, so please confirm your quantity is available prior to placing an order.
  • Branded Products: allow 10 business days from proof approval for production. Branding options may be limited or unavailable based on product design or cover artwork.
  • Unbranded Products: allow 3-5 business days for shipping. All Unbranded items receive FREE ground shipping in the US. Inquire for international shipping.
  • RETURNS/CANCELLATIONS: All orders, branded or unbranded, are NON-CANCELLABLE and NON-RETURNABLE once a purchase order has been received.
  • Product Details

    Author:
    Anindya Nag, Md. Mehedi Hassan, Asif Karim, Kishor Kumar Reddy C
    Format:
    Hardcover
    Pages:
    450
    Publisher:
    River Publishers,CRC Press (October 13, 2025)
    Imprint:
    River Publishers
    Language:
    English
    Audience:
    College/higher education
    ISBN-13:
    9788743801757
    Weight:
    35oz
    Dimensions:
    6.125" x 9.1875"
    File:
    TAYLORFRANCIS-TayFran_261008043303567-20261008.xml
    Folder:
    TAYLORFRANCIS
    List Price:
    $150.00
    Country of Origin:
    United States
    Pub Discount:
    30
    Series:
    River Publishers Series in Biomedical Engineering
    As low as:
    $142.50
    Publisher Identifier:
    P-CRC
    Discount Code:
    H
  • Overview

    This book explores the transformative power of AI in the domain of neurodegenerative diseases such as ALS, Parkinson’s, and Alzheimer’s. It explores AI-driven advancements in predictive analytics, biomarker discovery, drug development, and rehabilitation tools while addressing ethical, regulatory, and data privacy challenges.